# InterDigital, Inc.: financial statements, quarterly

IDCC · Nasdaq · CIK 1405495 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/idcc.md) · [Financials](/companies/idcc/financials.md) · [Filings](/companies/idcc/filings.md) · [Insiders](/companies/idcc/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/idcc/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [140](/filings/0001405495-24-000117.md) | [106 d](/filings/0001405495-26-000011.md) | [264](/filings/0001405495-25-000022.md) | [223](/filings/0001405495-25-000051.md) | [129](/filings/0001405495-25-000063.md) | [253 d](/filings/0001405495-26-000011.md) | [211](/filings/0001405495-26-000035.md) | [301](/filings/0001405495-26-000066.md) | [165](/filings/0001405495-25-000063.md) | [158 d](/filings/0001405495-26-000011.md) | [205](/filings/0001405495-26-000035.md) | [260](/filings/0001405495-26-000066.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating income | $m | [53.7](/filings/0001405495-24-000117.md) | [25.3 d](/filings/0001405495-26-000011.md) | [104](/filings/0001405495-25-000022.md) | [134](/filings/0001405495-25-000051.md) | [39.3](/filings/0001405495-25-000063.md) | [163 d](/filings/0001405495-26-000011.md) | [132](/filings/0001405495-26-000035.md) | [205](/filings/0001405495-26-000066.md) | [75.8](/filings/0001405495-25-000063.md) | [47.8 d](/filings/0001405495-26-000011.md) | [82.3](/filings/0001405495-26-000035.md) | [139](/filings/0001405495-26-000066.md) |
| Interest expense | $m | [12.7](/filings/0001405495-23-000044.md) | [7.9 d](/filings/0001405495-24-000052.md) | [11.9](/filings/0001405495-24-000072.md) | [11.5](/filings/0001405495-25-000051.md) | [10.7](/filings/0001405495-25-000063.md) | [11.3 d](/filings/0001405495-26-000011.md) | [9.9](/filings/0001405495-26-000035.md) | [9.5](/filings/0001405495-26-000066.md) | [10.0](/filings/0001405495-25-000063.md) | [10.5 d](/filings/0001405495-26-000011.md) | [9.1](/filings/0001405495-26-000035.md) | [8.6](/filings/0001405495-26-000066.md) |
| Income tax | $m | [8.5](/filings/0001405495-24-000117.md) | [(6.2) d](/filings/0001405495-26-000011.md) | [19.4](/filings/0001405495-25-000022.md) | [24.4](/filings/0001405495-25-000051.md) | [7.0](/filings/0001405495-25-000063.md) | [19.9 d](/filings/0001405495-26-000011.md) | [16.6](/filings/0001405495-26-000035.md) | [30.5](/filings/0001405495-26-000066.md) | [8.5](/filings/0001405495-25-000063.md) | [7.2 d](/filings/0001405495-26-000011.md) | [4.5](/filings/0001405495-26-000035.md) | [27.0](/filings/0001405495-26-000066.md) |
| Net income | $m | [47.9](/filings/0001405495-24-000117.md) | [39.1 d](/filings/0001405495-26-000011.md) | [81.7](/filings/0001405495-25-000063.md) | [110](/filings/0001405495-25-000063.md) | [34.2](/filings/0001405495-25-000063.md) | [133 d](/filings/0001405495-26-000011.md) | [116](/filings/0001405495-26-000066.md) | [181](/filings/0001405495-26-000066.md) | [67.5](/filings/0001405495-25-000063.md) | [43.0 d](/filings/0001405495-26-000011.md) | [75.3](/filings/0001405495-26-000066.md) | [116](/filings/0001405495-26-000066.md) |
| Diluted EPS | $ per share | [1.72](/filings/0001405495-24-000117.md) | not reported | [2.88](/filings/0001405495-25-000022.md) | [3.93](/filings/0001405495-25-000051.md) | [1.14](/filings/0001405495-25-000063.md) | not reported | [3.45](/filings/0001405495-26-000035.md) | [5.35](/filings/0001405495-26-000066.md) | [1.93](/filings/0001405495-25-000063.md) | not reported | [2.14](/filings/0001405495-26-000035.md) | [3.40](/filings/0001405495-26-000066.md) |
| Basic EPS | $ per share | [1.82](/filings/0001405495-24-000117.md) | not reported | [3.20](/filings/0001405495-25-000022.md) | [4.35](/filings/0001405495-25-000051.md) | [1.36](/filings/0001405495-25-000063.md) | not reported | [4.49](/filings/0001405495-26-000035.md) | [6.97](/filings/0001405495-26-000066.md) | [2.62](/filings/0001405495-25-000063.md) | not reported | [2.93](/filings/0001405495-26-000035.md) | [4.51](/filings/0001405495-26-000066.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Research and development: not reported
- Selling, general and administrative: not reported
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [518](/filings/0001405495-24-000117.md) | [437](/filings/0001405495-25-000011.md) | [440](/filings/0001405495-25-000022.md) | [300](/filings/0001405495-25-000051.md) | [401](/filings/0001405495-25-000063.md) | [527](/filings/0001405495-26-000011.md) | [537](/filings/0001405495-26-000035.md) | [518](/filings/0001405495-26-000066.md) | [840](/filings/0001405495-25-000063.md) | [739](/filings/0001405495-26-000066.md) | [608](/filings/0001405495-26-000035.md) | [616](/filings/0001405495-26-000066.md) |
| Current assets | $m | [1,258](/filings/0001405495-23-000044.md) | [1,168](/filings/0001405495-25-000011.md) | [1,215](/filings/0001405495-24-000072.md) | [1,057](/filings/0001405495-24-000103.md) | [1,154](/filings/0001405495-24-000117.md) | [1,231](/filings/0001405495-26-000011.md) | [1,242](/filings/0001405495-25-000022.md) | [1,386](/filings/0001405495-25-000051.md) | [1,481](/filings/0001405495-25-000063.md) | [1,388](/filings/0001405495-26-000066.md) | [1,387](/filings/0001405495-26-000035.md) | [1,397](/filings/0001405495-26-000066.md) |
| Total assets | $m | [1,826](/filings/0001405495-23-000044.md) | [1,771](/filings/0001405495-25-000011.md) | [1,807](/filings/0001405495-24-000072.md) | [1,636](/filings/0001405495-24-000103.md) | [1,725](/filings/0001405495-24-000117.md) | [1,836](/filings/0001405495-26-000011.md) | [1,862](/filings/0001405495-25-000022.md) | [1,985](/filings/0001405495-25-000051.md) | [2,140](/filings/0001405495-25-000063.md) | [2,064](/filings/0001405495-26-000066.md) | [2,071](/filings/0001405495-26-000035.md) | [2,192](/filings/0001405495-26-000066.md) |
| Current liabilities | $m | [445](/filings/0001405495-23-000044.md) | [881](/filings/0001405495-25-000011.md) | [904](/filings/0001405495-24-000072.md) | [699](/filings/0001405495-24-000103.md) | [712](/filings/0001405495-24-000117.md) | [726](/filings/0001405495-26-000011.md) | [704](/filings/0001405495-25-000022.md) | [709](/filings/0001405495-25-000051.md) | [785](/filings/0001405495-25-000063.md) | [753](/filings/0001405495-26-000066.md) | [738](/filings/0001405495-26-000035.md) | [801](/filings/0001405495-26-000066.md) |
| Total liabilities | $m | [1,239](/filings/0001405495-23-000044.md) | [1,189](/filings/0001405495-25-000011.md) | [1,183](/filings/0001405495-24-000072.md) | [940](/filings/0001405495-24-000103.md) | [1,003](/filings/0001405495-24-000117.md) | [978](/filings/0001405495-26-000011.md) | [925](/filings/0001405495-25-000022.md) | [898](/filings/0001405495-25-000051.md) | [1,040](/filings/0001405495-25-000063.md) | [963](/filings/0001405495-26-000066.md) | [967](/filings/0001405495-26-000035.md) | [990](/filings/0001405495-26-000066.md) |
| Long-term debt | $m | [485](/filings/0001405495-23-000044.md) | [29.0](/filings/0001405495-25-000011.md) | [28.0](/filings/0001405495-24-000072.md) | [17.7](/filings/0001405495-24-000103.md) | [18.3](/filings/0001405495-24-000117.md) | [15.4](/filings/0001405495-26-000011.md) | [16.0](/filings/0001405495-25-000022.md) | [16.6](/filings/0001405495-25-000051.md) | [17.1](/filings/0001405495-25-000063.md) | [16.3](/filings/0001405495-26-000066.md) | [10.5](/filings/0001405495-26-000035.md) | [10.9](/filings/0001405495-26-000066.md) |
| Current portion of debt | $m | [126](/filings/0001405495-23-000044.md) | [579](/filings/0001405495-25-000011.md) | [579](/filings/0001405495-24-000072.md) | [454](/filings/0001405495-24-000103.md) | [454](/filings/0001405495-24-000117.md) | [456](/filings/0001405495-26-000011.md) | [455](/filings/0001405495-25-000022.md) | [456](/filings/0001405495-25-000051.md) | [456](/filings/0001405495-25-000063.md) | [458](/filings/0001405495-26-000066.md) | [378](/filings/0001405495-26-000035.md) | [378](/filings/0001405495-26-000066.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [583](/filings/0001405495-23-000044.md) | [582](/filings/0001405495-25-000063.md) | [624](/filings/0001405495-25-000063.md) | [697](/filings/0001405495-25-000063.md) | [723](/filings/0001405495-25-000063.md) | [857](/filings/0001405495-26-000066.md) | [937](/filings/0001405495-26-000066.md) | [1,087](/filings/0001405495-26-000066.md) | [1,100](/filings/0001405495-25-000063.md) | [1,101](/filings/0001405495-26-000066.md) | [1,104](/filings/0001405495-26-000066.md) | [1,202](/filings/0001405495-26-000066.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [311 d](/filings/0001405495-24-000117.md) | [(23.6) d](/filings/0001405495-26-000011.md) | [50.8](/filings/0001405495-25-000022.md) | [(48.9) d](/filings/0001405495-25-000051.md) | [77.6 d](/filings/0001405495-25-000063.md) | [192 d](/filings/0001405495-26-000011.md) | [(20.0)](/filings/0001405495-26-000035.md) | [105 d](/filings/0001405495-26-000066.md) | [396 d](/filings/0001405495-25-000063.md) | [63.4 d](/filings/0001405495-26-000011.md) | [16.1](/filings/0001405495-26-000035.md) | [82.5 d](/filings/0001405495-26-000066.md) |
| Capital expenditure | $m | [0.6 d](/filings/0001405495-24-000117.md) | [1.1 d](/filings/0001405495-26-000011.md) | [0.4](/filings/0001405495-25-000022.md) | [0.6 d](/filings/0001405495-25-000051.md) | [0.9 d](/filings/0001405495-25-000063.md) | [3.9 d](/filings/0001405495-26-000011.md) | [14.5](/filings/0001405495-26-000035.md) | [0.6 d](/filings/0001405495-26-000066.md) | [0.6 d](/filings/0001405495-25-000063.md) | [0.2 d](/filings/0001405495-26-000011.md) | [0.9](/filings/0001405495-26-000035.md) | [1.6 d](/filings/0001405495-26-000066.md) |
| Dividends paid | $m | [9.3 d](/filings/0001405495-24-000117.md) | [10.3 d](/filings/0001405495-26-000011.md) | [10.2](/filings/0001405495-25-000022.md) | [10.1 d](/filings/0001405495-25-000051.md) | [10.1 d](/filings/0001405495-25-000063.md) | [11.4 d](/filings/0001405495-26-000011.md) | [11.6](/filings/0001405495-26-000035.md) | [15.6 d](/filings/0001405495-26-000066.md) | [15.5 d](/filings/0001405495-25-000063.md) | [18.0 d](/filings/0001405495-26-000011.md) | [18.0](/filings/0001405495-26-000035.md) | [18.1 d](/filings/0001405495-26-000066.md) |
| Share repurchases | $m | [56.9 d](/filings/0001405495-24-000117.md) | [37.0 d](/filings/0001405495-26-000011.md) | [28.9](/filings/0001405495-25-000022.md) | [34.8 d](/filings/0001405495-25-000051.md) | [3.1 d](/filings/0001405495-25-000063.md) | [0.0 d](/filings/0001405495-26-000011.md) | [5.2](/filings/0001405495-26-000035.md) | [26.2 d](/filings/0001405495-26-000066.md) | [35.3 d](/filings/0001405495-25-000063.md) | [35.7 d](/filings/0001405495-26-000011.md) | [8.2](/filings/0001405495-26-000035.md) | [23.0 d](/filings/0001405495-26-000066.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [29.9](/filings/0001405495-23-000044.md) | [29.4](/filings/0001405495-24-000072.md) | [27.7](/filings/0001405495-24-000103.md) | [27.8](/filings/0001405495-24-000117.md) | [28.3](/filings/0001405495-25-000022.md) | [27.9](/filings/0001405495-25-000051.md) | [30.0](/filings/0001405495-25-000063.md) | [33.5](/filings/0001405495-26-000035.md) | [33.7](/filings/0001405495-26-000066.md) | [34.9](/filings/0001405495-25-000063.md) | [35.3](/filings/0001405495-26-000035.md) | [34.3](/filings/0001405495-26-000066.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 25,806,007 at 2026-07-28, from the cover of the [10-Q filed 2026-07-30](/filings/0001405495-26-000066.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.